A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: The GAMMA trial

  1. Fuchs, C.S.
  2. Azevedo, S.
  3. Okusaka, T.
  4. Van Laethem, J.-L.
  5. Lipton, L.R.
  6. Riess, H.
  7. Szczylik, C.
  8. Moore, M.J.
  9. Peeters, M.
  10. Bodoky, G.
  11. Ikeda, M.
  12. Melichar, B.
  13. Nemecek, R.
  14. Ohkawa, S.
  15. Swieboda-Sadlej, A.
  16. Tjulandin, S.A.
  17. Van Cutsem, E.
  18. Loberg, R.
  19. Haddad, V.
  20. Gansert, J.L.
  21. Bach, B.A.
  22. Carrato, A.
Revue:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Année de publication: 2015

Volumen: 26

Número: 5

Pages: 921-927

Type: Article

DOI: 10.1093/ANNONC/MDV027 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus